𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of chronic hepatitis B and C virus infections

✍ Scribed by Voranush Chongsrisawat; Yong Poovorawan

Publisher
Springer-Verlag
Year
2002
Tongue
English
Weight
660 KB
Volume
69
Category
Article
ISSN
0019-5456

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Occult hepatitis B virus and hepatitis C
Occult hepatitis B virus and hepatitis C virus infections
✍ Vicente CarreΓ±o*; Javier BartolomΓ©; Inmaculada Castillo; Juan Antonio Quiroga πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 213 KB

## Abstract Occult HBV infection is a well‐recognised clinical entity characterised by the detection of HBV‐DNA in serum and/or in liver in the absence of detectable hepatitis B surface antigen (HBsAg). Occult HBV infection has been described not only in patients who have resolved an acute or chron

Concurrent hepatitis C virus and hepatit
Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection
✍ Yun-Fan Liaw; Rong-Nan Chien; Tong-Jong Chen; I-Shyan Sheen; Chia-Ming Chu πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 476 KB πŸ‘ 1 views

## Abstract Since hepatitis C virus (HCV) and hepatitis delta virus (HDV) are transmitted by the same routes as hepatitis B virus (HBV), simultaneous or concurrent HCV and HDV infection in patients with chronic HBV infection may occur. To test this hypothesis and to examine the clinicohistological

Leucocyte hepatitis B virus DNA in acute
Leucocyte hepatitis B virus DNA in acute and chronic hepatitis B virus infection
✍ F. Davison; G. J. M. Alexander; Ch. Anastassakos; E. A. Fagan; Roger Williams πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 444 KB πŸ‘ 1 views

In the present study we have investigated 53 patients with a spectrum of acute and chronic hepatitis B virus (HBV) infection for the presence of leucocyte HBV-DNA with the aid of molecular techniques. HBV-DNA was detected in peripheral blood mononuclear cells of 31 of 45 (69%) of chronic HBsAg carri